Menard Financial Group LLC Nevro Corp Transaction History

Menard Financial Group LLC

  • $146 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$81.07 - $121.29 $143,412 - $214,562
-1,769 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$101.99 - $166.36 $20,194 - $32,939
198 Added 12.6%
1,769 $206,000
Q2 2021

Aug 11, 2021
BUY
$141.6 - $179.06 $222,453 - $281,303
1,571 New
1,571 $260,000

Others Institutions Holding NVRO

# of Institutions
151
Shares Held
39.3M
Call Options Held
67.9K
Put Options Held
1.59M
View Full List

About NEVRO CORP

NVRO Quotes by TradingView
  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $160M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Menard Financial Group LLC Portfolio

Follow Menard Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Menard Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Menard Financial Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email